| Literature DB >> 30176820 |
Jie Shi1, Danwei Zheng2, Yankun Zhu2, Xiaoguang Ma2, Shaohua Wang2, Hui Li3, Jin Xing2.
Abstract
BACKGROUND: Tuberculosis remains a serious threat to human health as an infectious disease in China. Henan, a most populated province in China, has a high incidence of tuberculosis (TB). Though the genetic diversity of Mycobacterium tuberculosis (MTB) has been investigated in many regions, there have been only a few studies on the molecular characteristics and drug resistance phenotypes in Henan. This is the first study on the genetic profile of MTB from Henan.Entities:
Keywords: Henan Province; MIRU-VNTR; Mycobacterium tuberculosis; Spoligotyping
Mesh:
Year: 2018 PMID: 30176820 PMCID: PMC6122615 DOI: 10.1186/s12879-018-3351-y
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Spoligotypes shared by M. tuberculosis strains evaluated in this study
| Octonary code of Spoligotype | Spoligotyping | Familya | SITb | No.c | Prevalenced |
|---|---|---|---|---|---|
| 000000000003771 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ | BEIJING | 1 | 546 | 81.74% |
| 000000000003571 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■□■■■■■ | BEIJING-LIKE | 632 | 2 | 0.30% |
| 000000000003731 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■□■■■ | BEIJING-LIKE | 190 | 2 | 0.30% |
| 000000000000071 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■ | BEIJING-LIKE | ORPHAN | 1 | 0.15% |
| 000000000003661 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■□■■□■ | BEIJING-LIKE | 1651 | 1 | 0.15% |
| 000000000003751 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■□■■ | BEIJING-LIKE | 941 | 1 | 0.15% |
| 000000000000771 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■ | BEIJING-LIKE | 269 | 5 | 0.75% |
| 777,777,760,020,771 | ■■■■■■■■■■■■■■■■■■■■■■■□□□□□□□□■□□□□■■■■■■■ | H3 | 791 | 1 | 0.15% |
| 777,777,777,020,771 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□□□□■■■■■■■ | H3 | 1 | 0.15% | |
| 000000007760771 | □□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■□□□□■■■■■■■ | LAM3 and S /convergent | 4 | 1 | 0.15% |
| 777,777,777,613,771 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□■□■■■■■■■■■ | MANU1 | ORPHAN | 1 | 0.15% |
| 777,777,777,763,771 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□■■■■■■■■■ | MANU2 | 54 | 16 | 2.40% |
| 757,777,777,763,771 | ■■■■□■■■■■■■■■■■■■■■■■■■■■■■■■■■□□■■■■■■■■■ | MANU2 | ORPHAN | 2 | 0.30% |
| 777,737,777,763,771 | ■■■■■■■■■■■■□■■■■■■■■■■■■■■■■■■■□□■■■■■■■■■ | MANU2 | 583 | 1 | 0.15% |
| 777,777,577,763,771 | ■■■■■■■■■■■■■■■■■■■□■■■■■■■■■■■■□□■■■■■■■■■ | MANU2 | ORPHAN | 1 | 0.15% |
| 576,377,777,760,771 | ■□■■■■■■□□■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | S | 1211 | 1 | 0.15% |
| 777,777,777,760,771 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | T1 | 53 | 54 | 8.08% |
| 037777777760771 | □□□□■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | T1 | 272 | 1 | 0.15% |
| 577,777,777,760,771 | ■□■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | T1 | 334 | 1 | 0.15% |
| 777,703,777,760,771 | ■■■■■■■■■■■■□□□□■■■■■■■■■■■■■■■■□□□□■■■■■■■ | T1 | 102 | 1 | 0.15% |
| 777,777,437,760,771 | ■■■■■■■■■■■■■■■■■■■□□□■■■■■■■■■■□□□□■■■■■■■ | T1 | 1051 | 1 | 0.15% |
| 777,777,777,760,631 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■□□■■■ | T1 | 888 | 1 | 0.15% |
| 777,777,777,760,731 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□■■■ | T2 | 52 | 6 | 0.90% |
| 577,777,777,760,731 | ■□■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□■■■ | T2 | 1302 | 1 | 0.15% |
| 777,737,777,760,771 | ■■■■■■■■■■■■□■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | T3 | 37 | 8 | 1.20% |
| 577,737,777,760,771 | ■□■■■■■■■■■■□■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | T3 | ORPHAN | 2 | 0.30% |
| 777,777,777,760,011 | ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□□□□■■ | U | 1 | 0.15% | |
| 563,777,777,760,771 | ■□■■■□□■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ | unknowne | 1 | 0.15% | |
| 577,777,403,760,771 | ■□■■■■■■■■■■■■■■■■■□□□□□□■■■■■■■□□□□■■■■■■■ | unknown | 1 | 0.15% | |
| 703,777,760,000,771 | ■■■□□□□■■■■■■■■■■■■■■■■□□□□□□□□□□□□□■■■■■■■ | unknown | 1 | 0.15% | |
| 703,777,760,063,771 | ■■■□□□□■■■■■■■■■■■■■■■■□□□□□□□■■□□■■■■■■■■■ | unknown | 1 | 0.15% | |
| 741,777,777,760,731 | ■■■■□□□□■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□■■■ | unknown | 1 | 0.15% | |
| 777,660,007,460,771 | ■■■■■■■■■■■□■■□□□□□□□□□□■■■■□□■■□□□□■■■■■■■ | unknown | 1 | 0.15% | |
| 777,777,307,760,731 | ■■■■■■■■■■■■■■■■■■□■■□□□■■■■■■■■□□□□■■■□■■■ | unknown | 1 | 0.15% | |
| 777,777,775,760,631 | ■■■■■■■■■■■■■■■■■■■■■■■■■□■■■■■■□□□□■■□□■■■ | unknown | 1 | 0.15% |
aRepresenting spoligotype families annotated in SITVITWEB database
bSIT from SITVITWEB database
cNumber of strains with the same SIT
dPrevalence represents the percentage of isolates with a common SIT among all isolates in this study
eunknown represents the spoligotyping type which is not found in SITVITWEB database
Fig. 1Minimum spanning tree showing clustering by spoligotyping of 668 M.tuberculosis isolates from Henan. Each nodal point represents a cluster with identical genotypes, and the colour and size of the nodal points are relative to the number of strains within that cluster. Different colours are assigned to the different groups, and the colour code is indicated on the side
Allelic diversity of 26 different MIRU-VNTR loci among M.tuberculosis strains (n = 668)
| locus | HGDI (all strains) | HGDI (Beijing family) | HGDI (non-Beijing family) | Size range observed | 24-loci | 15-loci | 12-loci | 10-loci |
|---|---|---|---|---|---|---|---|---|
| qub-11b | 0.767 | 0.728 | 0.845 | 0–11 | √ | √ | √ | |
| mtub-21 | 0.644 | 0.564 | 0.762 | 1–8 | √ | √ | √ | |
| miru-26 | 0.616 | 0.541 | 0.817 | 1–12 | √ | √ | √ | √ |
| qub26 | 0.608 | 0.566 | 0.762 | 1–11 | √ | √ | √ | |
| mtub-04 | 0.516 | 0.460 | 0.690 | 1–6 | √ | √ | √ | |
| miru-10 | 0.451 | 0.357 | 0.639 | 1–6 | √ | √ | √ | √ |
| ETRF | 0.434 | 0.358 | 0.661 | 0–7 | √ | |||
| ETRE | 0.430 | 0.312 | 0.410 | 1–5 | √ | √ | √ | √ |
| miru-39 | 0.394 | 0.281 | 0.464 | 1–8 | √ | √ | √ | |
| ETRA | 0.329 | 0.236 | 0.565 | 1–5 | √ | √ | √ | |
| miru-40 | 0.326 | 0.243 | 0.589 | 0–5 | √ | √ | √ | |
| qub4156 | 0.322 | 0.315 | 0.357 | 1–8 | √ | √ | ||
| mtub-38 | 0.322 | 0.110 | 0.602 | 0–3 | ||||
| mtub-39 | 0.316 | 0.252 | 0.523 | 2–8 | √ | √ | ||
| mtub-30 | 0.308 | 0.168 | 0.502 | 2–5 | √ | √ | ||
| ETRB | 0.179 | 0.097 | 0.468 | 1–5 | √ | |||
| miru-27 | 0.175 | 0.117 | 0.413 | 1–4 | √ | √ | ||
| miru-16 | 0.172 | 0.120 | 0.396 | 1–5 | √ | √ | √ | |
| ETRD | 0.159 | 0.094 | 0.436 | 0–6 | √ | √ | √ | |
| ETRC | 0.109 | 0.097 | 0.172 | 2–5 | √ | √ | ||
| miru-23 | 0.109 | 0.090 | 0.203 | 1–6 | √ | √ | ||
| mtub29 | 0.096 | 0.077 | 0.187 | 2–6 | √ | |||
| vntr49 | 0.081 | 0.080 | 0.088 | 1–4 | √ | |||
| miru-20 | 0.030 | 0.028 | 0.036 | 1–2 | √ | √ | ||
| miru-2 | 0.015 | 0.014 | 0.018 | 1–3 | √ | √ | ||
| miru-24 | 0.015 | 0.007 | 0.054 | 1–3 | √ | √ | ||
| all | 0.998 | 0.998 | 0.999 |
Number of different patterns and unique strains, clustering percentage, clustering rate and HGDI for the different typing methods in this study
| Genotyping method | Number of pattern | Number of cluster | Number of clustered isolates | Number of isolates with unique profile | cluster rate (%) | HGDI |
|---|---|---|---|---|---|---|
| spoligotyping | 35 | 10 | 643 | 25 | 0.948 | 0.325 |
| 12-loci miru-vntr | 263 | 51 | 456 | 212 | 0.606 | 0.925 |
| 12loci + sp | 292 | 53 | 429 | 239 | 0.563 | 0.941 |
| 15-loci miru-vntr | 501 | 56 | 223 | 445 | 0.250 | 0.996 |
| 15loci + sp | 516 | 54 | 206 | 462 | 0.228 | 0.997 |
| 24-loci miru-vntr | 550 | 42 | 160 | 508 | 0.177 | 0.998 |
| 24loci + sp | 561 | 40 | 147 | 521 | 0.160 | 0.998 |
| 26-loci miru-vntr | 567 | 38 | 139 | 529 | 0.151 | 0.998 |
| 26loci + sp | 576 | 37 | 129 | 539 | 0.138 | 0.999 |
The cumulative HGDI with successive addition of each MIRU-VNTR locus
| VNTR locus | No. of pattern | No. of cluster | No. of cluster isolates | No. of isolates in each cluster | cluster rate (%) | HGDI (cumulative) | |
|---|---|---|---|---|---|---|---|
| 1 | Qub11b | ||||||
| 2 | mtub21 | 56 | 38 | 650 | 2–165 | 0.916 | 0.890 |
| 3 | miru26 | 158 | 69 | 579 | 2–122 | 0.763 | 0.940 |
| 4 | qub26 | 258 | 78 | 487 | 2–80 | 0.612 | 0.970 |
| 5 | mtub-04 | 318 | 80 | 430 | 2–59 | 0.524 | 0.982 |
| 6 | miru-10 | 356 | 84 | 396 | 2–49 | 0.467 | 0.988 |
| 7 | ETRF | 389 | 77 | 356 | 2–45 | 0.418 | 0.990 |
| 8 | ETRE | 420 | 72 | 320 | 2–42 | 0.371 | 0.992 |
| 9 | miru-39 | 444 | 76 | 300 | 2–35 | 0.335 | 0.994 |
| 10 | ETRA | 466 | 72 | 274 | 2–28 | 0.302 | 0.996 |
| 11 | miru-40 | 492 | 69 | 245 | 2–23 | 0.263 | 0.997 |
| 12 | qub4156 | 507 | 63 | 224 | 2–21 | 0.241 | 0.997 |
| 13 | mtub-38 | 512 | 62 | 218 | 2–21 | 0.234 | 0.997 |
| 14 | mtub-39 | 524 | 55 | 199 | 2–21 | 0.216 | 0.997 |
| 15 | mtub-30 | 528 | 53 | 193 | 2–20 | 0.210 | 0.997 |
| 16 | ETRB | 531 | 51 | 188 | 2–19 | 0.205 | 0.998 |
| 17 | miru-27 | 536 | 50 | 182 | 2–18 | 0.198 | 0.998 |
| 18 | miru-16 | 542 | 51 | 177 | 2–16 | 0.189 | 0.998 |
| 19 | ETRD | 548 | 46 | 166 | 2–15 | 0.180 | 0.998 |
| 20 | ETRC | 555 | 43 | 156 | 2–15 | 0.169 | 0.998 |
| 21 | miru-23 | 562 | 42 | 146 | 2–15 | 0.156 | 0.998 |
| 22 | mtub29 | 565 | 39 | 142 | 2–15 | 0.154 | 0.998 |
| 23 | vntr49 | 565 | 39 | 142 | 2–15 | 0.154 | 0.998 |
| 24 | miru-20 | 566 | 39 | 141 | 2–15 | 0.153 | 0.998 |
| 25 | miru-2 | 566 | 39 | 141 | 2–15 | 0.153 | 0.998 |
| 26 | miru-24 | 567 | 38 | 139 | 2–15 | 0.151 | 0.998 |
Differences in M. tuberculosis characteristics between the Beijing and non-Beijing families
| Drug susceptibility testing | total ( | Beijing family isolates( | Non-Beijing family isolates ( | OR | 95% CI | |
|---|---|---|---|---|---|---|
| Pan sensitive | 466 | 394 | 72 | 1.09 | 0.69–1.75 | 0.700 |
| Any resistance to | ||||||
| Isoniazid | 99 | 85 | 14 | 1.23 | 0.67–2.26 | 0.487 |
| Rifampin | 63 | 54 | 9 | 1.20 | 0.57–2.51 | 0.623 |
| Ethambutol | 42 | 38 | 4 | 1.56 | 0.54–4.50 | 0.415 |
| Streptomycin | 129 | 108 | 21 | 1.01 | 0.65–1.71 | 0.946 |
| Kanamycin | 28 | 20 | 8 | 2.11 | 0.90–4.92 | 0.078 |
| ofloxacin | 58 | 44 | 14 | 1.79 | 0.94–3.41 | 0.072 |
| All four first-line drugs resistance | 30 | 29 | 1 | 5.97 | 1.05–44.33 | 0.045 |
| MDR-TB | 50 | 47 | 3 | 3.28 | 1.01–10.37 | 0.038 |
| Pre-XDR-TB | 17 | 16 | 1 | 3.21 | 0.42–24.51 | 0.332 |
| XDR-TB | 11 | 10 | 1 | 1.99 | 0.25–15.69 | 1.001 |
OR odds ratio, CI confidence interval
MDR-TB: multi-drug resistance TB, resistant to at least isoniazid and rifampicin
XDR-TB: extensively drug-resistant tuberculosis, MDR-TB plus resistance to ofloxacin and kanamycin
Pre-XDR-TB: MDR-TB plus resistance to either ofloxacin or kanamycin
First-line drugs resistance: resistant to isoniazid, rifampin, ethambutol and streptomycin
Epidemiological characteristics of the Beijing and non-Beijing isolates
| characteristics | total ( | Beijing family isolates ( | Non-Beijing family isolates ( | OR | 95% CI | |
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 509 | 428 | 81 | |||
| Female | 159 | 130 | 29 | 0.85 | 0.53–1.35 | 0.541 |
| Age group,years | ||||||
| < 25 | 141 | 113 | 28 | |||
| 25–44 | 197 | 161 | 36 | 0.71 | 0.39–1.31 | 0.282 |
| 45–64 | 177 | 154 | 23 | 0.79 | 0.45–1.40 | 0.422 |
| > 64 | 153 | 130 | 23 | 1.19 | 0.63–2.20 | 0.587 |
| Treatment history | ||||||
| New case | 501 | 422 | 79 | |||
| Retreatment case | 167 | 136 | 31 | 1.22 | 0.77–1.92 | 0.398 |
| Population | ||||||
| Permanent | 134 | 111 | 23 | |||
| Migrant | 534 | 447 | 87 | 1.06 | 0.64–1.76 | 0.804 |